Literature DB >> 24780631

Body weight and body composition of depot medroxyprogesterone acetate users.

Natália Dal'Ava1, Luis Bahamondes2, M Valeria Bahamondes2, Bruna F Bottura2, Ilza Monteiro2.   

Abstract

OBJECTIVES: Weight gain is a concern with the contraceptive depot-medroxyprogesterone acetate (DMPA); however, this issue remains controversial. The objective of this study was to compare body weight (BW) and body composition (BC) in DMPA and copper intrauterine device (IUD) users at baseline and after one year of use. STUDY
DESIGN: We enrolled new DMPA users and age and weight matched new IUD users into this prospective study. Weight and height were measured, BC (fat and lean mass) was evaluated using dual-energy X-ray absorptiometry, and physical activity was assessed at baseline and at 12 months. Student's paired t test and the Wilcoxon paired test for matched samples were used.
RESULTS: Ninety-seven women were enrolled for the study; 26 matched pairs continued using the initial method for at least one year, and completed the baseline and 12 month assessments. An increase of 1.9 kg occurred in BW (p=.02) in DMPA users at 12 months of use, resulting from an increase in fat mass of 1.6 kg (p=.03). Weight remained stable in IUD users; however, there was an increase in lean mass at 12 months of use (p=.001). The number of women practicing physical activity increased in this group. There was a significant difference between the groups regarding the variation in the percentage of central fat (p=.04).
CONCLUSION: Weight gain in the DMPA group after the first year of use resulted from an increase in fat mass. Weight remained stable in the IUD group; however, an increase in lean mass and a reduction in localized abdominal fat mass occurred, possibly because more users were practicing physical activity. IMPLICATIONS STATEMENT: There was a greater increase in body weight in DMPA users compared to TCu380A IUD users in the first year of use of the contraceptive method. Furthermore, the weight increase in users of DMPA occurred principally as the result of an increase in fat mass. Physical activity probably could increase the lean mass in the users of TCu380A IUD.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Body mass; DMPA; Dual-energy X-ray absorptiometry; Fat mass; Hormonal contraceptives; Lean mass

Mesh:

Substances:

Year:  2014        PMID: 24780631     DOI: 10.1016/j.contraception.2014.03.011

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  5 in total

Review 1.  Ovarian hormones and obesity.

Authors:  Brigitte Leeners; Nori Geary; Philippe N Tobler; Lori Asarian
Journal:  Hum Reprod Update       Date:  2017-05-01       Impact factor: 15.610

2.  Changes in body weight and blood pressure among women using Depo-Provera injection in Northwest Ethiopia.

Authors:  Muluken Fekadie Zerihun; Tabarak Malik; Yohannes Mulu Ferede; Tesfahun Bekele; Yigizie Yeshaw
Journal:  BMC Res Notes       Date:  2019-08-15

3.  Anthropometric indices, blood pressure, and lipid profile status among women using progestin-only contraceptives: comparative cross-sectional study.

Authors:  Mulu Shiferaw; Woldeteklehaymanot Kassahun; Belay Zawdie
Journal:  BMC Womens Health       Date:  2021-01-23       Impact factor: 2.809

4.  Weight change among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Findings from a randomised, multicentre, open-label trial.

Authors:  Mags Beksinska; Rodal Issema; Ivana Beesham; Tharnija Lalbahadur; Katherine Thomas; Charles Morrison; G Justus Hofmeyr; Petrus S Steyn; Nelly Mugo; Thesla Palanee-Phillips; Khatija Ahmed; Gonasagrie Nair; Jared M Baeten; Jenni Smit
Journal:  EClinicalMedicine       Date:  2021-04-06

Review 5.  Progestin-only contraceptives: effects on weight.

Authors:  Laureen M Lopez; Shanthi Ramesh; Mario Chen; Alison Edelman; Conrad Otterness; James Trussell; Frans M Helmerhorst
Journal:  Cochrane Database Syst Rev       Date:  2016-08-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.